| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,338 |
1,267 |
$189K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,319 |
1,282 |
$129K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
690 |
681 |
$93K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
642 |
627 |
$54K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,251 |
1,171 |
$53K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
224 |
221 |
$49K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
254 |
250 |
$36K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
977 |
932 |
$26K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
562 |
556 |
$20K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
89 |
77 |
$19K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
226 |
220 |
$18K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
163 |
157 |
$14K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
164 |
157 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
478 |
445 |
$10K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
98 |
97 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
215 |
205 |
$4K |
| 81025 |
|
223 |
218 |
$3K |
| 81002 |
|
540 |
521 |
$3K |